Freidinger RM - Search Results

1

Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.

Bock MG, DiPardo RM, Rittle KE, Evans BE, Freidinger RM, Veber DF, Chang RS, Chen TB, Keegan ME, Lotti VJ. Bock MG, et al. Among authors: freidinger rm. J Med Chem. 1986 Oct;29(10):1941-5. doi: 10.1021/jm00160a024. J Med Chem. 1986. PMID: 3761313

2

Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DF, Freidinger RM, Chang RS, Chen TB, Lotti VJ. Bock MG, et al. Among authors: freidinger rm. J Med Chem. 1990 Jan;33(1):450-5. doi: 10.1021/jm00163a069. J Med Chem. 1990. PMID: 2153212

3

Novel glutamic acid derived cholecystokinin receptor ligands.

Freidinger RM, Whitter WL, Gould NP, Holloway MK, Chang RS, Lotti VJ. Freidinger RM, et al. J Med Chem. 1990 Feb;33(2):591-5. doi: 10.1021/jm00164a020. J Med Chem. 1990. PMID: 2299627

4

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RS, et al. Evans BE, et al. Among authors: freidinger rm. J Med Chem. 1988 Dec;31(12):2235-46. doi: 10.1021/jm00120a002. J Med Chem. 1988. PMID: 2848124

5

Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.

Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Gould NP, Lundell GF, Homnick CF, Veber DF, et al. Evans BE, et al. Among authors: freidinger rm. J Med Chem. 1987 Jul;30(7):1229-39. doi: 10.1021/jm00390a019. J Med Chem. 1987. PMID: 2885419

6

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS, Freidinger RM. Bock MG, et al. Among authors: freidinger rm. J Med Chem. 1989 Jan;32(1):13-6. doi: 10.1021/jm00121a004. J Med Chem. 1989. PMID: 2909725 No abstract available.

7

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency.

Bock MG, DiPardo RM, Evans BE, Freidinger RM, Rittle KE, Payne LS, Boger J, Whitter WL, LaMont BI, Ulm EH, et al. Bock MG, et al. Among authors: freidinger rm. J Med Chem. 1988 Oct;31(10):1918-23. doi: 10.1021/jm00118a009. J Med Chem. 1988. PMID: 3050088

8

Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Veber DF, Freidinger RM, Chang RS, Lotti VJ. Bock MG, et al. Among authors: freidinger rm. J Med Chem. 1988 Jan;31(1):176-81. doi: 10.1021/jm00396a028. J Med Chem. 1988. PMID: 3336017

9

Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Freidinger RM, Chang RS, Lotti VJ. Bock MG, et al. Among authors: freidinger rm. J Med Chem. 1988 Jan;31(1):264-8. doi: 10.1021/jm00396a042. J Med Chem. 1988. PMID: 3336026 No abstract available.

10

Benzodiazepines as potent and selective bradykinin B1 antagonists.

Wood MR, Kim JJ, Han W, Dorsey BD, Homnick CF, DiPardo RM, Kuduk SD, MacNeil T, Murphy KL, Lis EV, Ransom RW, Stump GL, Lynch JJ, O'Malley SS, Miller PJ, Chen TB, Harrell CM, Chang RS, Sandhu P, Ellis JD, Bondiskey PJ, Pettibone DJ, Freidinger RM, Bock MG. Wood MR, et al. Among authors: freidinger rm. J Med Chem. 2003 May 8;46(10):1803-6. doi: 10.1021/jm034020y. J Med Chem. 2003. PMID: 12723943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page